Mandibulectomy is a surgical procedure to remove all or part of the lower jaw bone (mandible) affected by cancer, followed by reconstruction to restore jaw function and facial form. Dr. Antony Raj James has specialized training in head and neck oncology and extensive experience in complex jaw cancer surgery and reconstruction.
A mandibulectomy involves the surgical removal of a segment or the entire lower jawbone when it is directly involved by cancer or when tumor clearance requires bone resection. There are two main types:
Surgery is considered when oral cavity cancers — such as those of the gum (gingiva), floor of mouth, cheek lining, or tongue — involve or are in close proximity to the mandible. Imaging assessment and tumour-board review guide surgical planning. The extent of bone resection is determined by tumor involvement and the requirement to achieve adequate surgical margins.
Dr. James has experience in complex oral cavity resections including T4 compartmental clearance and procedures involving the mandible. Surgery is planned to achieve appropriate oncological clearance while considering the need for functional and cosmetic reconstruction. The approach may be transoral, transcervical, or combined, depending on tumor location and extent.
Jaw and oral cavity cancers frequently require simultaneous evaluation and treatment of regional lymph nodes. Dr. James has extensive experience with radical, comprehensive, and selective neck dissections across levels I–V, performed concurrently with mandibulectomy when indicated.
Reconstruction after jaw resection is essential to restore chewing, swallowing, speech, and facial appearance. Dr. James has experience with pedicled reconstructive flaps, including PMMC and other regional flaps, used to reconstruct soft tissue defects following mandibulectomy. Reconstruction planning is individualized based on the extent of the defect and the patient's overall treatment requirements.
Jaw bone cancers require coordinated care involving head and neck surgery, radiation oncology, medical oncology, maxillofacial surgery, and pathology teams. Dr. James participates in multidisciplinary tumour-board discussions to develop individualized, evidence-based treatment plans for each patient.